Result
The result fell in 2023 from -€2,973 to -€60,429.
The result fell in 2023 from -€2,973 to -€60,429.
The 2018 accounts came latest: 153 days after the end of the period.
Absorbed by REDPHARMA in April 2024. The last annual accounts are for financial year 2023.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette.
Staff costs divided by the average number of full-time equivalents.
| Line | Trend | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Balance sheet: assets | ||||||||||
20/58 |
615,295 | 706,645 | 752,656 | 500,248 | 530,570 | 565,358 | 492,511 | 394,903 | 157,704 | |
21/28 |
1,504 | 3,976 | 6,398 | 8,135 | 17,868 | 19,613 | 29,694 | 32,677 | 4,700 | |
21 |
623 | 2,493 | 4,320 | 6,120 | 8,186 | 1,585 | 2,902 | 4,221 | 4,700 | |
22/27 |
880 | 1,484 | 2,078 | 2,015 | 9,683 | 18,029 | 26,709 | 28,373 | - | |
23 |
- | - | - | 53 | 1,799 | 3,546 | 5,293 | 6,777 | - | |
24 |
880 | 1,484 | 2,078 | 1,962 | 3,730 | 6,175 | 8,955 | 4,980 | - | |
28 |
- | - | - | - | - | - | 84 | 84 | - | |
29/58 |
613,791 | 702,668 | 746,258 | 492,113 | 512,702 | 545,744 | 462,817 | 362,226 | 153,004 | |
40/41 |
279,339 | 228,437 | 333,038 | 307,941 | 360,876 | 377,670 | 310,483 | 248,522 | 79,606 | |
40 |
221,056 | 192,924 | 333,038 | 307,941 | 357,009 | 343,095 | 306,135 | 248,522 | 79,606 | |
41 |
58,284 | 35,513 | - | - | 3,868 | 34,575 | 4,347 | - | - | |
54/58 |
334,355 | 474,231 | 413,220 | 183,362 | 151,244 | 167,493 | 152,335 | 113,704 | 73,398 | |
490/1 |
97 | - | - | 810 | 581 | 581 | - | - | - | |
| Balance sheet: equity and liabilities | ||||||||||
10/49 |
615,295 | 706,645 | 752,656 | 500,248 | 530,570 | 565,358 | 492,511 | 394,903 | 157,704 | |
10/15 |
465,587 | 526,015 | 516,589 | 279,827 | 273,612 | 198,741 | 179,001 | 41,701 | 6,685 | |
10/11 |
18,600 | 18,600 | 6,200 | 6,200 | 6,200 | 6,200 | 6,200 | 6,200 | 6,200 | |
100 |
- | - | - | - | 18,600 | 18,600 | 18,600 | 18,600 | 18,600 | |
101 |
- | - | - | - | 12,400 | 12,400 | 12,400 | 12,400 | 12,400 | |
13 |
1,860 | 1,860 | 1,860 | 1,860 | 1,860 | 1,860 | 1,860 | 1,860 | 485 | |
130/1 |
1,860 | 1,860 | 1,860 | 1,860 | - | - | - | - | - | |
130 |
- | - | - | - | 1,860 | 1,860 | 1,860 | 1,860 | 485 | |
1311 |
1,860 | 1,860 | 1,860 | 1,860 | - | - | - | - | - | |
14 |
445,127 | 505,555 | 508,529 | 271,767 | 265,552 | 190,681 | 170,941 | 33,641 | - | |
17/49 |
149,708 | 180,629 | 236,067 | 220,420 | 256,958 | 366,616 | 313,510 | 353,202 | 151,019 | |
17 |
- | - | - | - | - | 4,873 | 9,633 | 12,722 | - | |
170/4 |
- | - | - | - | - | 4,873 | 9,633 | 12,722 | - | |
42/48 |
149,708 | 180,629 | 217,286 | 220,084 | 256,958 | 361,743 | 287,877 | 247,625 | 46,862 | |
42 |
- | - | - | - | 4,410 | 3,590 | 3,089 | 2,937 | - | |
44 |
111,512 | 145,436 | 145,321 | 183,421 | 187,581 | 255,155 | 176,666 | 189,241 | 25,114 | |
440/4 |
111,512 | 145,436 | 145,321 | 183,421 | 187,581 | 255,155 | 176,666 | 189,241 | 25,114 | |
46 |
- | - | - | - | - | 2,200 | - | - | - | |
45 |
38,196 | 35,193 | 71,965 | 36,663 | 64,922 | 100,797 | 108,122 | 55,447 | 21,748 | |
450/3 |
11,421 | 22,500 | 65,632 | 33,202 | 58,468 | 92,875 | 102,860 | 49,062 | 21,748 | |
454/9 |
26,775 | 12,693 | 6,332 | 3,461 | 6,454 | 7,923 | 5,262 | 6,384 | - | |
47/48 |
- | - | - | - | 44 | - | - | - | - | |
492/3 |
- | 0 | 18,781 | 336 | - | 1 | 16,000 | 92,855 | 104,157 | |
| Income statement | ||||||||||
70 |
- | - | 1.1m | 671,375 | 761,467 | 910,371 | - | - | - | |
76A |
- | - | - | 771 | 1,567 | - | - | - | - | |
9900 |
89,692 | 66,272 | 342,713 | 92,231 | 206,238 | 208,146 | 283,134 | 112,832 | 2,297 | |
60/61 |
- | - | 772,572 | 601,090 | 559,370 | 708,741 | - | - | - | |
62 |
153,112 | 65,985 | 37,850 | 56,234 | 97,290 | 130,977 | 55,601 | 39,334 | - | |
630 |
2,473 | 2,422 | 3,167 | 9,734 | 10,745 | 11,130 | 11,036 | 9,154 | 1,055 | |
631/4 |
2,420 | 0 | -16,480 | 4,838 | -12,300 | 29,117 | - | - | - | |
640/8 |
0 | 206 | 4,015 | 1,613 | 731 | 1,093 | 1,921 | 2,059 | 348 | |
66A |
- | 0 | 8,117 | 10,403 | 8,553 | - | - | - | - | |
9901 |
-68,313 | -2,340 | 306,045 | 9,410 | 101,219 | 35,830 | 214,576 | 62,284 | 894 | |
75/76B |
12,733 | 457 | 14,738 | 1,959 | 10,256 | 2,142 | - | 19 | 51 | |
75 |
12,733 | 457 | 14,738 | 1,959 | 10,256 | 2,142 | - | 19 | 51 | |
65/66B |
2,457 | 690 | 1,180 | 1,246 | 1,303 | 1,589 | 929 | 756 | 10 | |
65 |
2,457 | 690 | 1,180 | 1,246 | 1,303 | 1,589 | 929 | 756 | 10 | |
9903 |
-58,037 | -2,573 | 319,603 | 10,123 | 110,172 | 36,383 | 213,647 | 61,547 | 935 | |
67/77 |
2,392 | 400 | 82,841 | 3,908 | 35,301 | 16,643 | 76,346 | 26,531 | 450 | |
9904 |
-60,429 | -2,973 | 236,761 | 6,215 | 74,871 | 19,740 | 137,301 | 35,016 | 485 | |
9905 |
-60,429 | -2,973 | 236,761 | 6,215 | 74,871 | 19,740 | 137,301 | 35,016 | 485 | |
| Appropriation of the result | ||||||||||
9906 |
445,127 | 505,555 | 508,529 | 271,767 | 265,552 | 190,681 | 170,941 | 35,016 | 485 | |
14P |
505,555 | 508,529 | 271,767 | - | - | - | - | - | - | |
691/2 |
- | - | - | - | - | - | - | 1,375 | 485 | |
6920 |
- | - | - | - | - | - | - | 1,375 | 485 | |
| Social balance sheet | ||||||||||
9087 |
2 | 2 | 1 | 1.2 | 1.9 | 2.7 | 1.3 | 0.8 | - | |
Hours worked1013 |
3,388 | 2,059 | 1,721 | 2,003 | 3,222 | 4,420 | 1,914 | 1,398 | - | |
| Document | ||||||||||
The notes to these accounts have 12 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the filed accounts (PDF).
Source: Annual accounts 2023 (PDF), filed on 15-07-2024.
| Financial year | Type | Filed | Reference | Document |
|---|---|---|---|---|
| 31-12-2023 | abbreviated format | 15-07-2024 | 2024-00260460 | |
| 31-12-2022 | abbreviated format | 31-08-2023 | 2023-00426721 | |
| 31-12-2021 | full format | 13-06-2022 | 2022-20071215 | |
| 31-12-2020 | full format | 02-08-2021 | 2021-46700442 | |
| 31-12-2019 | full format | 13-10-2020 | 2020-61600362 | |
| 31-12-2018 | full format | 31-12-2019 | 2019-77900547 | |
| 31-12-2017 | micro format | 27-09-2018 | 2018-65800226 | |
| 31-12-2016 | micro format | 16-08-2017 | 2017-45800007 | |
| 31-12-2015 | abbreviated format | 12-08-2016 | 2016-42800372 |
| Line | Trend | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| -65,840 | 81 | 309,211 | 19,143 | 111,964 | 46,959 | 225,612 | 71,439 | 1,949 | ||
| -57,956 | -552 | 239,928 | 15,949 | 85,616 | 30,869 | 148,337 | 44,170 | 1,540 | ||
| 0 | 0 | 1,430 | 0 | 9,000 | 1,132 | 8,054 | 37,131 | 5,755 | ||
| -139,876 | 61,011 | 229,858 | 32,118 | -16,248 | 15,158 | 38,630 | 40,306 | - | ||
| 464,083 | 522,039 | 528,972 | 272,029 | 255,744 | 184,002 | 174,940 | 114,600 | 106,142 | ||
| - | - | 27.7% | 1.4% | 13.3% | 3.9% | - | - | - | ||
| 75.7% | 74.4% | 68.6% | 55.9% | 51.6% | 35.2% | 36.3% | 10.6% | 4.2% | ||
| 4.10 | 3.89 | 3.43 | 2.24 | 2.00 | 1.51 | 1.61 | 1.46 | 3.26 | ||
| 0.32 | 0.34 | 0.46 | 0.79 | 0.94 | 1.84 | 1.75 | 8.47 | 22.59 | ||
| -13.0% | -0.6% | 45.8% | 2.2% | 27.4% | 9.9% | 76.7% | 84.0% | 7.3% | ||
| -9.8% | -0.4% | 31.5% | 1.2% | 14.1% | 3.5% | 27.9% | 8.9% | 0.3% | ||
| -26.80 | 0.12 | over 100 | - | - | - | - | - | - | ||
| - | - | 110 days | 167 days | 171 days | 138 days | - | - | - | ||
| - | - | 69 days | 111 days | 122 days | 131 days | - | - | - |
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
| Item | 31-12-2023 | 31-12-2022 | 31-12-2021 |
|---|---|---|---|
| Employees at the balance-sheet date | 2 | 2 | 1 |
| full-time | 2 | 2 | 1 |
| part-time | 0 | 0 | - |
| in full-time equivalents | 2 | 2 | 1 |
| 2 | 2 | 1 | |
| On a permanent contract | 2 | 2 | 1 |
| Joined | - | 1 | - |
| Left | - | 0 | - |
Source: social balance sheet in the 2021 to 2023 annual accounts
| Item | 2023 | 2022 | 2021 |
|---|---|---|---|
| Tangible fixed assets | - | - | €1,430 |
| €2,473 | €2,422 | €3,167 |
Source: notes to the 2021 to 2023 annual accounts (statement of fixed assets)
The operating result for 2023 is a loss of €68,313, larger than the loss of €2,340 in 2022. It is the lowest result since 2015.
Debt's share of the balance-sheet total falls from 25.6% to 24.3%. Equity and debt are lower.
Further up the chainIQVIA Solutions Belgium 100%IQVIA AG 99.99%IQVIA HOLDINGS INC. US consolidates
Source: parent in its own accounts, lists of holdings in the owners' accounts
Source: list of holdings in the 2023 accounts of REDPHARMA. Every holding stands with its own latest accounts.
The network starts from the directors of MTOUCH. Every other company they run is a node.
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
deed of 26-08-2022 (in Dutch)
MTOUCH is no longer in the KBO register. REDPHARMA took it over in a merger by absorption, published in the Belgian Official Gazette on 14 June 2024.
If something looks wrong or is missing, please tell us.